Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

ClinicalTrials.gov ID: NCT03439514

Public ClinicalTrials.gov record NCT03439514. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 11:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled study in patients with dilated cardiomyopathy (DCM) due to a mutation of the gene encoding the lamin A/C protein (LMNA). The study will further evaluate a dose level of study drug (ARRY-371797) that has shown preliminary efficacy and safety in this patient population. After the primary analysis has been performed, eligible patients may receive open-label treatment with ARRY-371797.

Study identification

NCT ID
NCT03439514
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
77 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 17, 2018 (Actual)
Primary completion
Oct 13, 2022 (Actual)
Completion
Oct 13, 2022 (Actual)
Last update posted
Jan 9, 2024

2018 – 2022

United States locations

U.S. sites
56
U.S. states
21
U.S. cities
29
Facility City State ZIP Site status
University of Alabama at Birmingham Hospital Birmingham Alabama 35233 —
University of Alabama at Birmingham the Kirklin Clinic Birmingham Alabama 35233 —
IDS Pharmacy at UAB Hospital Birmingham Alabama 35249 —
Cardiovascular Clinical Trials Unit Birmingham Alabama 35294 —
CB Flock Research Corporation Mobile Alabama 36608 —
Chandler Regional Medical Center Chandler Arizona 85224 —
Valley Heart Rhythm Specialists, PLLC Chandler Arizona 85224 —
Cardiovascular and Stem Cell Consultants Gilbert Arizona 85297-0425 —
Cardiovascular Research Clinic Gilbert Arizona 85297-0425 —
Dignity Health, Mercy Gilbert Medical Center Gilbert Arizona 85297-0425 —
Mercy Gilbert Medical Center Gilbert Arizona 85297 —
Children's Clinic Tucson Arizona 85712 —
Banner - Banner University Medical Center South Tucson Arizona 85713 —
Banner - University Medical Center Tucson Tucson Arizona 85719 —
Banner University Medicine North Tucson Arizona 85719 —
Banner University Medical Center Tuscon Tucson Arizona 85724 —
University of Arizona Sarver Heart Center Tucson Arizona 85724 —
Ahmanson Cardiomyopathy Center Cardiovascular Genetics Los Angeles California 90095 —
Stanford Hospital and Clinics Stanford California 94305 —
University of Colorado Academic Offices Building Aurora Colorado 80045 —
University of Colorado Clinical and Translational Research Center Aurora Colorado 80045 —
University of Colorado Hospital Aurora Colorado 80045 —
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010 —
Innovative Research of West Florida Clearwater Florida 33756 —
University of South Florida Tampa Florida 33606-3601 —
USF Health Tampa Florida 33606 —
Florida Cardiovascular Institute PA Tampa Florida 33609 —
Centers for Heart Failure Therapy Atlanta Georgia 30322 —
Emory University Hospital Atlanta Georgia 30322 —
Columbus Cardiology Associates Research - Centricity Research - HyperCore - PPDS Columbus Georgia 31904-6877 —
Columbus Cardiology Associates Research - IACT - HyperCore - PPDS Columbus Georgia 31904-6877 —
Columbus Regional Research Institute at Talbotton - Centricity Research - HyperCore - PPDS Columbus Georgia 31904-8946 —
Columbus Regional Research Institute Columbus Georgia 31904 —
Saint Luke's Idaho Cardiology Associates Boise Idaho 83712-6246 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
MyMichigan Medical Center Midland Midland Michigan 48670 —
Washington University Center For Advanced Medicine St Louis Missouri 63110 —
Washington University Center for Outpatient Health St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Rutgers New Jersey Medical School - Doctors Office Center Newark New Jersey 07103 —
Newark Beth Israel Medical Center Newark New Jersey 07112 —
NYU School of Medicine / NYU Langone Health New York New York 10016 —
Columbia University Irving Medical Center New York New York 10032 —
Columbia University/Presbyterian Hospital - Vivian & Seymour Milstein Family Heart Center New York New York 10032 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Ohio State University Wexner Medical Center Columbus Ohio 43210 —
University of Pennsylvania Hospital Philadelphia Pennsylvania 19104 —
Medical University of South Carolina - PPDS Charleston South Carolina 29425-8911 —
Medical University of South Carolina - PPDS Charleston South Carolina 29425 —
Stern Cardiovascular Foundation Inc Germantown Tennessee 38138 —
Tennessee Center for Clinical Trials Tullahoma Tennessee 37388 —
Baylor Scott and White Heart and Vascular Hospital Dallas Texas 75226 —
Baylor Annette C and Harold C Simmons Transplant Institute Dallas Texas 75246 —
Intermountain Medical Center Murray Utah 84107 —
University of Washington Medical Center Seattle Washington 98195 —
Meriter Hospital Madison Wisconsin 53713 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03439514, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 9, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03439514 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →